|
2019
|
Invention
|
Methods of treating disorders related to glycemic control. Disclosed herein, in part, are methods... |
|
|
Invention
|
Fumagillol type compounds and methods of making and using same.
The disclosure provides fumagill... |
|
2018
|
Invention
|
Targeting compounds. The disclosure provides, at least in part, liver, intestine and/or kidney-ta... |
|
|
Invention
|
Fumagillol spirocyclic compounds and fused bicyclic compounds and methods of making and using sam... |
|
|
Invention
|
Fumagillol heterocyclic compounds and methods of making and using same.
Disclosed herein, in par... |
|
|
Invention
|
Methods of treating an overweight or obese subject.
The invention generally relates to methods o... |
|
|
Invention
|
Methods of treating age related disorders.
The invention generally relates to methods of treatin... |
|
|
Invention
|
Methods of treating an overweight or obese subject.
The invention herein generally relates to ph... |
|
|
Invention
|
Pharmaceutical compositions of metap-2 inhibitors.
Disclosed herein, in part, are pharmaceutical... |
|
|
Invention
|
Methods for identifying metap-2 modulators.
Disclosed herein, in part, are methods for identifyi... |
|
|
Invention
|
Methods for identifying metap-2 modulators. Disclosed herein, in part, are methods for identifyin... |
|
|
Invention
|
Pharmaceutical compositions of metap-2 inhibitors. Disclosed herein, in part, are pharmaceutical ... |
|
|
Invention
|
Fumigillol compounds and methods of making and using same. The disclosure provides fumagillol typ... |
|
2017
|
Invention
|
Methods of treating ischemic organ damage and other disorders. The invention generally relates to... |
|
|
Invention
|
Treatment of obesity using non-daily administration of 6-o-(4-dimethylaminoethoxy) cinnamoyl fuma... |
|
|
Invention
|
Fumagillol compounds and methods of making and using same.
Disclosed herein, in part, are fumagi... |
|
|
Invention
|
Fumagillol compounds and methods of making and using same. Disclosed herein, in part, are fumagil... |
|
|
Invention
|
Methods of treating an overweight or obese subject.
The disclosure herein generally relates to m... |
|
|
Invention
|
Oxaspiro[2.5]octane derivatives and analogs. The invention provides oxaspiro[2.5]octane derivativ... |
|
|
Invention
|
Fumagillol heterocyclic compounds and methods of making and using same. Disclosed herein, in part... |
|
|
Invention
|
Methods of treating an overweight subject. The invention generally relates in part to methods of ... |
|
|
Invention
|
Partially saturated tricyclic compounds and methods of making and using same.
The invention prov... |
|
|
Invention
|
Methods of treating impaired wound healing. The invention generally relates to methods of treatin... |
|
2016
|
Invention
|
Methods of treating liver diseases. The invention provides tricyclic compounds and their use in t... |
|
|
Invention
|
Inclusion compounds of fumagillol derivative or its salt, and pharmaceutical compositions compris... |
|
|
Invention
|
Fumagillol spirocyclic compounds and fused bicyclic compounds and their use as metap2 inhibitors.... |
|
|
Invention
|
Crystalline solids of a metap-2 inhibitor and methods of making and using same. The disclosure is... |
|
|
Invention
|
Methods of treating an overweight or obese subject. The invention herein generally relates to pha... |
|
|
Invention
|
Oxaspiro[2.5]octane derivatives and analogs.
The invention provides oxaspiro[2.5]octane derivati... |
|
|
Invention
|
Partially saturated tricyclic compounds and methods of making and using same. The invention provi... |
|
|
Invention
|
Tricyclic compounds and methods of making and using same. The invention provides tricyclic compou... |
|
2015
|
Invention
|
Tricyclic pyrazole sulphonamide compounds and methods of making and using same.
The invention pr... |
|
|
Invention
|
Aryl-substituted tricyclic sulfonamides as methionyl aminopeptidase 2 modulators. The invention p... |
|
|
Invention
|
Lyophilized compositions containing a metap-2 inhibitor.
This disclosure features compositions (... |
|
|
Invention
|
Methods and compositions for treating cardiovascular disorders.
The invention generally relates ... |
|
|
Invention
|
Fumagillol type compounds and methods of making and using same.
The disclosure provides a fumagi... |
|
2013
|
Invention
|
Tricyclic sulphonamide compounds and methods of making and using same. The invention provides tri... |
|
2008
|
P/S
|
Pharmaceutical research and development; medical research; medical and scientific research in the... |
